The use of intercostal nerve block (ICNB) for thoracic surgery can reduce pain in the first 24 hours after surgery and decrease opioid use, according to a systematic review and meta-analysis, ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced results from its second pivotal, Phase 3 clinical trial assessing the safety and efficacy of EXPAREL® ...

Effective pain control after video-assisted thoracic surgery (VATS) is critical because of the correlation between postoperative pain and recovery after surgery. Due to the limitations of traditional ...

A single-shot intercostal nerve block was noninferior to thoracic epidural analgesia for pain control in minimally invasive lung resection. Continuous paravertebral block came out inferior for pain ...

The study did not meet its primary endpoint of reducing cumulative pain scores over a three day period. Detailed data from the study is expected in the coming few weeks. This phase III portion of the ...

Exparel, a product of Pacira Pharmaceuticals (NASDAQ:PCRX), is one of the leading non-opioid analgesics in pain management. Pacira is a rising specialty pharmaceutical company focused on ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced results from its second pivotal, Phase 3 clinical trial assessing the safety and efficacy of EXPAREL ® ...